Pain Management Market Analysis and Reports | Switzerland Conference Series

Market Analysis - Pain Management 2018

Market Analysis

The global pain management therapeutics market has enormous possibility for growth due to the large population that is affected by medically significant pain. The market is growing at a reasonable growth rate, driven by the cancer pain, low back pain and post-operative pain relief markets. In 2010, the global pain management therapeutics market was estimated at $28.6 billion, representing a CAGR of 5.3% between 2002 and 2010. The post-operative pain relief market, with sales of $5.9 billion in 2010, accounted for one fifth of the total pain management therapeutics market. The low back pain market, with sales of $4.9 billion, was the second largest market segment, with a share of 17% of the worldwide pain management therapeutics market. The low back pain market is followed by the cancer pain and neuropathic pain relief markets, accounting for 16% each of the global pain management therapeutics market.

The global pain management market is driven by anticonvulsant Lyrica and anti-depressant Cymbalta, which are expected to expire in 2013. By 2017, the global pain management therapeutics market is forecast to generate sales of $35.1 billion, representing a CAGR of 3.0% between 2010 and 2017.

Conference Series LLC organizes 1000+ Global events annually across the globe with support from 1000+ more scientific societies and Publishes 700 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

 

Why Switzerland?

A compact presence of universities, hospitals and other professional services, together make it a favourite destination for scientific meetings. Switzerland encompasses the great diversity of landscapes and climates. Switzerland has a stable, prosperous and high-tech economy and enjoys great wealth, being ranked as the wealthiest country in the world. Switzerland is home to several large multinational corporations. Switzerland was found to be happiest country in the world in the third annual Happiness report. Zürich and Geneva each have been ranked among the top cities with the highest quality of life in the world. Switzerland is a leading global city in the arts, commerce, education, finance, healthcare, media, professional services, research and development, tourism, and transport. The Switzerland economy is conquered by Machinery, chemicals, watches, textiles, instruments, tourism, banking, insurance, pharmaceuticals and much more.

Zürich which is a leading global city, is the largest city in Switzerland with many museums and art galleries, including the Swiss National Museum and the Kunsthaus. Schauspielhaus Zürich is one of the most important theatres in the German-speaking world.

Conference Highlights

Interventional Pain Management

Pain Management and Rehabilitation

Pain Control Techniques

Pain Medication

Pain Syndrome

NSAIDs and Analgesics

Pharmacological Approaches for Pain

Non-Pharmacological Approaches for Pain

Arthritis & Inflammation

Pain assessment Tools

Cancer Pain Management

Pediatric Pain Management

Orofacial Pain

Pain Management Nursing

Clinical Manifestations & Epidemiology of Pain

Neuropathic Pain & Neuro Orthopaedics

Acute Pancreatitis

Pain Management Market